Xingyin Pharmaceutical development is divided into four stages:
Aircraft Carrier -- (2015-2025)
In 2015:
In February, Star Silver Investment Group made a one-time payment to purchase 410 square meters of office space on the north side of the 10th floor of the International Trade Building.
On March 4, Xingyin Investment Group held a signing ceremony for the new polypeptide drug industrialization production base project in Xian \'an, Hubei Province. The project is located in Xian \'an Economic Development Zone, covering a total area of 660 acres, the first phase covers an area of more than 300 acres, construction projects include headquarters conference, training, reception base, new peptide API production base, peptide preparation production base, information center and research and development center.
In May, the company was certified as "the most competitive Enterprise in Guangdong in 2014" by the evaluation committee of Guangdong Enterprise Competitiveness Promotion Association.
On May 13, the company won the title of "Top 15 Internet Spirit Enterprises in this century" in the selection of "Top 15 Internet Spirit Enterprises in this Century" sponsored by "Pharmaceutical Economic News" and "E Drug Manager".
In December, Guangdong Pharmaceutical Industry Association awarded "Mai Zhiling Film 2015 Excellent Product brand in Guangdong Pharmaceutical Industry" and awarded Shenzhen Star Silver Pharmaceutical Co., Ltd. "2015 Top Ten comprehensive strength of Guangdong Pharmaceutical commercial Enterprises".
In 2016:
From January 15 to 19, the 21st Sales Work Conference and 2015 annual Commendation Conference of Xingyin Pharmaceutical was held in Nanjing Xingyin Industrial Park. The theme of the conference is "Take on, Perform and Go Beyond".
In March, approved by the evaluation committee of Guangdong Enterprise Competitiveness Promotion Association, Shenzhen Xingyin Pharmaceutical Co., Ltd. was rated as "the most competitive enterprise in Guangdong in 2015", and "Mai Zhiling Tablet" was awarded "the most competitive brand in Guangdong in 2015".
On May 23, the third Strategic cooperation Business Association of Star Silver Medicine was held in Sheraton Dameisha Hotel, Shenzhen, and the leaders of nearly 100 mainstream commercial companies and retail chain companies attended the meeting. The meeting received attention from government leaders at all levels and industry media.
In 2017:
On January 21, the Shenzhen Famous Brand Evaluation Committee conducted a review of the 14th declaration of Shenzhen famous brands, and determined that the "Xingyin Pharmaceutical" brand passed the review and won the "Shenzhen famous brand" again.
From July 14 to 16, the company held the 2016 annual commendation Conference and the 2017 half-year sales work summary meeting in Nanjing Xingyin Pharmaceutical Industrial Park. The theme of this conference is "Academic training, professional win the future".
On August 16, the chairman of the company led the distribution division to participate in the Heap event held in Boao. As a representative of the strugglers, the chairman attended the "Honor and Mission" theme dinner and accepted the praise of the industry.
On August 18, the 2017 annual "Healthy China · Brand List" listed brand award ceremony was held in Boao. After years of market accumulation and precipitation, Star Silver Pharmaceutical\'s flagship product Maizhiling Tablet was awarded the 2017 annual "Healthy China · Brand List" hemorrhoid medicine listed brand.
From December 28 to 29, 2017 Luohu District Chief Quality Award Evaluation expert Group visited Xingyin Pharmaceutical Headquarters to conduct on-site evaluation on enterprise comprehensive management and business performance.
In 2018:
On January 11, Xingyin Pharmaceutical Trade Union has been outstanding in safeguarding the rights and interests of employees and creating double love enterprises for many years, and has won the honor of "Excellent grass-roots trade union of Nanhu Street Enterprise" for two consecutive years.
From March 3 to March 8, the 23rd National Sales Work Conference and Commendation Conference of Xingyin Pharmaceutical was held in Huizhou, Guangdong Province, with the theme of "Change for development, linkage for new highs".
On April 25, Xingyin Pharmaceutical obtained the "Shenzhen Corporate Social Responsibility Evaluation three-star Certificate".
In April, under the joint efforts of all departments, after strict material preparation and on-site review, and finally through the voting results of the expert committee and on-site statistics, Xingyin Medicine won the "2017 Annual District Chief Quality Award".
On August 12, 2018, the Xipu Grand Event was held in Boao, Hainan, and Star Silver Medicine was invited to attend. With its excellent clinical efficacy and high safety, the star product of Star Silver Medicine, Mazhiling Tablet, has been awarded the "Healthy China Brand List" of hemorrhoid drugs for four consecutive years, and the chairman of the board has been promoted by the industry as the "climber" over the new decade.
In 2019
On February 25, the 24th sales work summary and commendation meeting of Xingyin Medicine was successfully held in Xianning, Hubei Province. The theme of this conference is "New starting point, New Journey, New leap".
On June 30, Shenzhen Xingyin Pharmaceutical Co., Ltd. was elected as "Demonstration unit of Shenzhen non-public Enterprise Party Building Hundred Enterprises".
On July 10, Chen Weisheng, deputy secretary of the Party Working Committee of Nanhu Street and director of the Working Committee of the National People\'s Congress, Liao Shubiao, member of the Party Working Committee of Nanhu Street and Minister of the development and renewal Department, Xie Yuanshan, representative of the District People\'s Congress, and the relevant responsible comrades of the development and renewal Department of the District visited our company to investigate and guide the work. After the investigation, Weng Jianrong, president of the Luohu District Folk Music Volunteer Association, presented a banner to the chairman of the board and expressed his gratitude to Xingyin Medicine for its charitable work in the charity activities.
On September 26, the 7th page of the "Medical Economic News" published a special report titled "Xingyin Medicine, taking advantage of the development of 40 years of reform and opening up" to celebrate the 70th anniversary of the founding of New China. This article comprehensively displays the development achievements of Xingyin Pharmaceutical in the past 25 years, in addition to print media, the official website of Medical Economic News, wechat public account, and headlines are simultaneously sent.
On November 8, Luohu\'s "two-week release" Hi-Tech Fair special press conference was held at the Party and Mass Service Center in Luohu District. Shenzhen Xingyin Pharmaceutical Co., Ltd. as a national high-tech enterprise, at the invitation of Luohu District Science and Technology Innovation Bureau, with innovative peptide products - Yi Ting high-end beauty skin care products appeared at this conference.
In December 2019, Guangdong Provincial Enterprise Competitiveness Promotion Association awarded our company the medal of "Top 500 Guangdong Enterprise Competitiveness in 2019".
In 2020
On January 17, Xingyin Pharmaceutical successfully passed the preliminary review of intellectual property management system certification, and obtained the "Intellectual Property Management System Certification Certificate" on February 9.
On March 10, Qi Zhiqing, leader of the Community Community Service Liaison Group of Shenzhen COVID-19 Epidemic Prevention Headquarters and head of the Municipal Party Committee Organization Department, and other leaders visited Xingyin to investigate the situation of our company\'s epidemic prevention and control, resumption of work and production and party building.
On May 18, the signing ceremony of the strategic cooperation between Xingyin Pharmaceutical and Chinese pharmacies was held at Xingyin Pharmaceutical headquarters.
On August 14, at the 2020 Xipu Gold Award ceremony, Maizhiling Tablet won the 2020 "Healthy China Brand List" hemorrhoid medicine list brand.
On October 22, Xingyin Medicine won the medal of "Top 100 Tax Paying Enterprises in Luohu District in 2019" issued by the People\'s Government of Luohu District.
On November 18, Xingyin Pharmaceutical passed the on-site evaluation of Shenzhen Corporate Social Responsibility Promotion Association with 185 points (full score of 200 points), and was rated as "Shenzhen Corporate Social Responsibility Evaluation Four-star enterprise", and won the title of "China · Shenzhen Integrity and Social Responsibility Demonstration Enterprise".
In 2021
In January, Xingyin Medicine obtained the certificate of "Luohu District Key Service \'through train\' Enterprise" issued by Luohu District People\'s Government Office.
On March 28, at the sixth Xiding Meeting, Star Silver Medicine Mai Zhiling Tablet won the "2021 China Drug District and County retail Market Brand List · Brand Front List" listed brands.
On April 24, the R&D department of Shenzhen Xingyin Pharmaceutical Co., Ltd. won the "Shenzhen Workers Pioneer" in 2021.
On May 7, at the second Shenzhen Brand Building Promotion Conference, Xingyin Pharmaceutical was named on the list of "Shenzhen Top 100 Brands".
On May 10, Jiangsu Brand Association issued the medal of "Outstanding Contribution to Brand Building for Ten Years" to Nanjing Xingyin Pharmaceutical Group Co., LTD.
On June 1, Shenzhen Xingyin Pharmaceutical Co., Ltd. won the honorary title of "Guangdong Province Contract-abiding and creditworthy Enterprise" for 10 consecutive years.
From September 23 to 28, at the 2021 Xipu meeting, Star Silver Medicine entered the "star" era 2021 category strategic project was officially launched, and Mai Zhiling Tablet won the TOP brand of "2020-2021 Health Industry · Brand Development Index".
On October 29, the "Advancing Double District Construction, Yong Dang Quality Pioneer" 2021 Shenzhen Top 500 Enterprise list release and the fourth "Shenzhen Top 100 Industry Leaders" award ceremony was held in Shenzhen, Shenzhen Star Silver Pharmaceutical Co., Ltd. won the "2021 Shenzhen Top 500 Enterprise List".
On November 3, the 2nd Shenzhen High-quality Development Summit Forum and 2021 Shenzhen high-quality Development Leading Enterprises Leading Figures Award Ceremony was held, and Mr. Liu Tingfu, chairman of the company, was awarded "2021 Shenzhen high-quality Development Leading Figures".
On December 27, the 23rd China International High-tech Fair opened, Star Silver Medicine with Luohu Group for the third time to bring high-tech products - Yi Ting polypeptide skin care products, Guipu medical nutrition weight reduction products appeared in Shenzhen International Convention and Exhibition Center, attracting the attention of many media, to inject innovative vitality for new Luohu.
In 2022
In January, Star Silver Medicine won the plaque of "Luohu Charity Alliance Enterprise".
In February, Nanjing Xingyin Pharmaceutical Group was awarded the "2021 Meritorious Unit" medal by Nanjing Lishui Economic Development Zone.
In April, Xingyin Medicine won the medal of "Excellent Unit of Jiabei Community Yi \'Jiabei\' Volunteer Service Team" issued by Jiabei Community Party Committee.
In April, Xingyin Pharmaceutical and Yaodou signed a strategic cooperation agreement in Beijing to jointly promote the digital development of pharmaceutical companies.
On May 18, the first batch of trial production in the automated extraction workshop of Nanjing Xingyin Pharmaceutical Group was successfully completed. The successful promotion of this technological transformation project marks the development of Xingyin Pharmaceutical industry to a new level.
In May, the brand selection results of the 2021-2022 Xiding Award were released, and Xingyin Medicine Maizhiling Tablet was once again listed on the "2021-2022 Pharmaceutical retail market Potential Brand" with core indicators such as brand strength, brand growth and brand accessibility.
In August, Xingyin Medicine won the title of the 19th "Shenzhen Famous Brand".
In September, Mr. Liu Tingfu, chairman of Xingyin Pharmaceutical, won the honorary certificate of "Luohu District Excellent Employee Friend".
In September, Shenzhen Xingyin Pharmaceutical Co., Ltd. won the "2022 Shenzhen Top 500 Enterprises List", ranking 364th.
On September 27-29, the 26th sales summary and commendation meeting of Xingyin Medicine was successfully held in Nanjing. At the meeting, Chairman Liu Tingfu delivered a keynote speech titled "Dedication, courage and perseverance".
In November, at the event of "Top of Glory, Shoulder to shoulder with You -2022 Heap Gold Award Ceremony", Star Silver Medicine Maizhiling Film won the Heap Gold Award of "2021-2022 Health Industry Brand List".
In November, the national medical insurance class B product produced by Shenzhen Jianxiang Biopharmaceutical Co., LTD., a subsidiary of Xingyin Pharmaceutical Group, Telipressin injection (trade name: Jiantai Xin) has passed the approval of the State Food and Drug Administration, which is regarded as approved by the consistency evaluation.
From December 17 to 19, Nanjing Xingyin Pharmaceutical Group\'s new automated extraction production line - Gegen Tang mixture extract production line, oral liquid workshop production line, after a three-day GMP compliance inspection, finally passed, and obtained the Jiangsu Provincial Drug Administration production drug record number.
2023年
On January 13, two drugs, "Somarlutide" and "Liraglutide", were awarded the certificate of famous high-tech products in Guangdong Province, further consolidating the competitive advantage of Jianyuan Medicine in the domestic market.
On February 24, Nanjing Xingyin Pharmaceutical Group Co., Ltd. won the certificate and medal of "Provincial High-tech Enterprise".
On March 15, Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. and Shenzhen Jianxiang Biopharmaceutical Co., Ltd. were successfully recognized as "specialized and special new" enterprises in Shenzhen in 2022.
On April 7, Xingyin Pharmaceutical won the second prize of "2020-2021 National Enterprise Culture Excellent Achievements".
On April 28, Liu Kaihao, general manager of Shenzhen Xingyin Pharmaceutical Co., Ltd. won the "Shenzhen May Day Labor Medal".
On August 4, the healthy Xin ® Cabetin injection produced by Nanjing Xingyin Pharmaceutical Group passed the generic drug quality and efficacy consistency evaluation issued by the State Drug Administration.
On August 4 and 5, the stomatitis spray produced by Nanjing Xingyin Pharmaceutical Group passed the GMP compliance evaluation.
On August 11, 2023 Xipu Association issued the "2023 Health industry Brand List", and Xingyin Medicine Maizhiling Tablet was honored in the "2023 Health Industry Brand List" varicose veins and hemorrhoids medication selection.
On September 25, Shenzhen Enterprise Federation and Shenzhen Entrepreneurs Association officially released the "2023 Shenzhen Top 500 Enterprises List" and the "2023 Shenzhen Top 500 Enterprises Development Report". Shenzhen Xingyin Pharmaceutical Co., Ltd. again ranked 326th on the list.
On September 28, Gentaidine ® terlipressin for injection, produced by Nanjing Xingyin Pharmaceutical Group, passed the evaluation of generic drug quality and efficacy consistency.
On November 25, in order to establish the "peptide drug innovation industry Alliance" as the theme, the "pilot base" innovation platform unveiling ceremony held by Jianyuan Pharmaceutical and Hubei Jianxiang Biopharmaceutical Co., Ltd. was held in Shenzhen Pingshan.
On December 6, Shenzhen Star Silver Pharmaceutical Co., LTD., School of Finance and Public Administration of Anhui University of Finance and Economics, Guangzhou Pharmaceutical Co., LTD., carried out a tripartite co-construction communication meeting, and held a ceremony to build a college student internship practice base.
On December 8, Shenzhen Star Silver Pharmaceutical Co., Ltd. was awarded the "Shenzhen Corporate Social Responsibility Evaluation Four-star Enterprise".
On December 18, Shenzhen Xingyin Pharmaceutical Co., Ltd. passed the strict evaluation and won the title of "Guangdong Province Integrity Management Enterprise in 2022" issued by Guangdong Market Association.
